Iovance Biotherapeutics, Inc. (IOVA)

Healthcare · Biotechnology · NASDAQ

Iovance Biotherapeutics, Inc. (IOVA) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.87B and a free-cash-flow yield of -14.8%. Over the most recent reported fiscal year, revenue grew 60.6%.

Market cap	$2.87B
Trailing P/E	—
FCF yield	-14.8%
Revenue growth (YoY)	+60.6%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live IOVA data on Nama Insights →